Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Balloon-expandable vs. self-expandable TAVR valves | Cardiologist the highest-paying job in 2 states | IVL for TLE
Thursday, June 29, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Balloon-expandable valves deliver better short-term TAVR outcomes than self-expandable valves

A new meta-analysis, published in Frontiers in Cardiovascular Medicine, focused on data from nearly 3,000 patients with severe symptomatic aortic stenosis.

READ MORE >
The Edwards Lifesciences Sapien transcatheter aortic valve replacement (TAVR) device in a heart model used to show patients how the device works.
Share on Twitter Share on Facebook Share on Linkedin

Balloon-expandable valves deliver better short-term TAVR outcomes than self-expandable valves

Share on Twitter Share on Facebook Share on Linkedin
The Edwards Lifesciences Sapien transcatheter aortic valve replacement (TAVR) device in a heart model used to show patients how the device works.
A new meta-analysis, published in Frontiers in Cardiovascular Medicine, focused on data from nearly 3,000 patients with severe symptomatic aortic stenosis.
READ MORE >

Cardiologists earn the highest annual salary in 2 states

According to new data out of the U.S. Department of Labor, physicians have the highest-paying jobs in a majority of states. Cardiologists specifically rank No. 1 in two different states. 

READ MORE >
cardiologist patient heart compensation starting salary 2022 interventional cardiologist
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists earn the highest annual salary in 2 states

Share on Twitter Share on Facebook Share on Linkedin
cardiologist patient heart compensation starting salary 2022 interventional cardiologist
According to new data out of the U.S. Department of Labor, physicians have the highest-paying jobs in a majority of states. Cardiologists specifically rank No. 1 in two different states. 
READ MORE >

Intravascular lithotripsy helps address the challenges of transvenous lead extraction

Dense calcifications have long been viewed as one of the most challenging aspects of TLE procedures. IVL may offer specialists a new way to address that issue. 

READ MORE >
Shockwave Medical's intravascular lithotripsy used during transvenous lead extraction
Share on Twitter Share on Facebook Share on Linkedin

Intravascular lithotripsy helps address the challenges of transvenous lead extraction

Share on Twitter Share on Facebook Share on Linkedin
Shockwave Medical's intravascular lithotripsy used during transvenous lead extraction
Dense calcifications have long been viewed as one of the most challenging aspects of TLE procedures. IVL may offer specialists a new way to address that issue. 
READ MORE >

Featured Articles

FDA announces recall of more than 250,000 interventional devices due to risk of catheter separation

The FDA has said this is a Class I recall, which means using the devices “may cause serious injuries or death.” A total of 18 injuries have been reported so far. 

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of more than 250,000 interventional devices due to risk of catheter separation

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
The FDA has said this is a Class I recall, which means using the devices “may cause serious injuries or death.” A total of 18 injuries have been reported so far. 
READ MORE >

Cardiology group faces class-action lawsuit after cyberattack exposed patients’ personal data

Patients learned that their names, social security numbers, banking numbers and credit card information were all potentially exposed as a result of the attack.

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Cardiology group faces class-action lawsuit after cyberattack exposed patients’ personal data

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
Patients learned that their names, social security numbers, banking numbers and credit card information were all potentially exposed as a result of the attack.
READ MORE >

What will Lodoco cost? Looking ahead after FDA’s historic approval of colchicine for CVD

“Our pricing strategy for Lodoco is focused on helping to ensure access to as many people as possible,” an executive with Agepha Pharma told Cardiovascular Business. 

READ MORE >
Colchicine Lodoco Agepha Pharma price cost cardiovascular disease CVD
Share on Twitter Share on Facebook Share on Linkedin

What will Lodoco cost? Looking ahead after FDA’s historic approval of colchicine for CVD

Share on Twitter Share on Facebook Share on Linkedin
Colchicine Lodoco Agepha Pharma price cost cardiovascular disease CVD
“Our pricing strategy for Lodoco is focused on helping to ensure access to as many people as possible,” an executive with Agepha Pharma told Cardiovascular Business. 
READ MORE >

In Case You Missed It

FDA clears first ablation catheter with flexible electrode tip, contact force sensing

Contact force-sensing catheters were developed to help overcome the issue of incomplete ablation lesions.

READ MORE >
Abbott's TactiFlex flexible tip, force sensing ablation catheter (right), and its integration with the EnSite X EP mapping system (left) showing the distance from the last ablation. and the contact force during an AFib pulmonary vein isolation.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears first ablation catheter with flexible electrode tip, contact force sensing

Share on Twitter Share on Facebook Share on Linkedin
Abbott's TactiFlex flexible tip, force sensing ablation catheter (right), and its integration with the EnSite X EP mapping system (left) showing the distance from the last ablation. and the contact force during an AFib pulmonary vein isolation.
Contact force-sensing catheters were developed to help overcome the issue of incomplete ablation lesions.
READ MORE >

Cardiologists shed new light on treating severe tricuspid regurgitation in high-risk heart failure patients

The 80-year-old patient was experiencing severe TR and already had a HeartMate II LVAD. 

READ MORE >
TricValve Transcatheter Bicaval Valves System and HeartMate II LVAD. A team of interventional cardiologists has made a bit of history, using a new transcatheter device to treat tricuspid regurgitation (TR) in a high-risk heart failure patient who with a previously implanted left ventricular assist device (LVAD). It represents the first time this particular device, the TricValve Transcatheter Bicaval Valves System from P+F Products, has been implanted in a patient with this particular LVAD, the HeartMate II.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists shed new light on treating severe tricuspid regurgitation in high-risk heart failure patients

Share on Twitter Share on Facebook Share on Linkedin
TricValve Transcatheter Bicaval Valves System and HeartMate II LVAD. A team of interventional cardiologists has made a bit of history, using a new transcatheter device to treat tricuspid regurgitation (TR) in a high-risk heart failure patient who with a previously implanted left ventricular assist device (LVAD). It represents the first time this particular device, the TricValve Transcatheter Bicaval Valves System from P+F Products, has been implanted in a patient with this particular LVAD, the HeartMate II.
The 80-year-old patient was experiencing severe TR and already had a HeartMate II LVAD. 
READ MORE >

In Other News

Primary care pay increases outpaced other specialties in 2022

That's according to new data from AMGA Consulting’s 36th annual Medical Group Compensation and Productivity Survey, which includes data from 446 medical groups, representing over 193,000 providers.

READ MORE >
physician money payments dollars
Share on Twitter Share on Facebook Share on Linkedin

Primary care pay increases outpaced other specialties in 2022

Share on Twitter Share on Facebook Share on Linkedin
physician money payments dollars
That's according to new data from AMGA Consulting’s 36th annual Medical Group Compensation and Productivity Survey, which includes data from 446 medical groups, representing over 193,000 providers.
READ MORE >

Former Johnson & Johnson sales rep indicted for defrauding hospital out of hundreds of thousands of dollars

The sales representative is alleged to have falsely documented his sales numbers on invoices submitted to the hospital’s billing department in addition to interfering with their sterilization processes, according to the DOJ.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Former Johnson & Johnson sales rep indicted for defrauding hospital out of hundreds of thousands of dollars

Share on Twitter Share on Facebook Share on Linkedin
The sales representative is alleged to have falsely documented his sales numbers on invoices submitted to the hospital’s billing department in addition to interfering with their sterilization processes, according to the DOJ.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Reprocessed medical devices recalled | CGM sensor issue linked to 860 serious injuries | Managing patients with high-risk leads
Potential downsides to AI | Surgery bests GLP-1 drugs | MiniMed seeks $7.9B valuation | AHA launches women's health initiative
Statin labels need an update | A new obstacle for Medicare patients | EP catheters recalled | FDA approves lead for LBBAP
It’s getting harder to see a cardiologist | 3D echo & young patients | FDA approves pacing lead for LBBAP | TAVR & radiotherapy
Cardiologist details benefits of new legislation | A 'striking shift' in TAVR data | Death after PCI | HoFH research
Week in Review: TAVR linked to higher reintervention risk | CCTA an essential tool | New PE guidelines | Delaying payment cuts
A big update to the Evolut Low Risk trial | Robotic cardiac surgery | Cardiologist develops new device | Tricuspid valve trends

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …23
    • Page 24
    • Page 25
    • Page 26
    • Current page 27
    • Page 28
    • Page 29
    • Page 30
    • Page 31 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup